Craft

XPhyto Therapeutics

Stock Price

$0.5

2023-01-13

Revenue

$27 K

FY, 2024

XPhyto Therapeutics Summary

Company Summary

Overview
XPhyto Therapeutics is a company engaged in researching and developing pharmaceutical and diagnostic products. It offers peri-implantitis oral biosensors, diagnostic kits, transdermal patches, oral dissolvable films, etc. The company is also involved in clinical studies of psychedelics and drug delivery methods.
Type
Public
Status
Active
Founded
2017
Website
https://xphyto.com/
Cybersecurity rating
Sectors

Table of Contents

XPhyto Therapeutics Financials

Summary Financials

Revenue (Q3, 2025)
$C11.0K
Gross profit (Q3, 2025)
$C11.0K
Net income (Q3, 2025)
($C1.6M)
Cash (Q3, 2025)
$C469.0K
EBIT (Q3, 2025)
($C1.3M)
Enterprise value
$6.3M

Footer menu